Skip to content
Awesome – Lifestyle
Author:
GENPREX, INC.
Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging
October 22, 2026
Genprex Presents Gene Therapy Pipeline at H.C. Wainwright Conference
September 8, 2026
Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa® Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat Cancer
June 22, 2026